$AWHL

Aspira Women's Health Inc.

Insider trades

No enriched coverage for $AWHL in the last 7 days.

No SEC Form 4 filings for $AWHL in the last 30 days.

See all $AWHL insider activity →
Med

Aspira Women's Health Inc. (AWHL): Entry into a Material Definitive Agreement

Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 awhl-20260706xex10d1.htm EX-10.1 ​ SUBORDINATED BUSINESS LOAN AND SECURITY AGREEMENT ​ ​ THIS SUBORDINATED BUSINESS LOAN AND SECURITY AGREEMENT (as the same may be amended, restated, modified, or supplemented from time to time, this “ Agreement ”) dated as of July 01, 2

Aspira Women's Health Inc. (AWHL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Aspira Women's Health Inc._ June 17, 2026 Aspira Women's Health Inc. 0000926617 false 0000926617 2025-12-16 2025-12-16 ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC

Aspira Women's Health Inc. (AWHL): Submission of Matters to a Vote of Security Holders

Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Aspira Women's Health Inc._June 17, 2026 Aspira Women's Health Inc. 0000926617 false 0000926617 2026-01-30 2026-01-30 ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

AWHL sentiment & insider activity

Recent AWHL coverage spans corporate actions and insider activity.

What's driving AWHL

  • The 8-K discloses a new subordinated term loan structure and repayment mechanics, which can affect leverage, liquidity, and credit risk perception.

    SEC EDGAR 8-K · Jul 15, 2026

  • Leadership transition via 8-K can shift near-term execution risk and investor sentiment, especially with separation terms still pending.

    SEC EDGAR 8-K · Jun 22, 2026

  • Routine shareholder-meeting outcomes; the only potentially tradable item is stock-incentive plan share authorization, but no financial guidance or transaction is disclosed.

    SEC EDGAR 8-K · Jun 17, 2026

  • Insider buying can be a modest sentiment tailwind, but this is not a fundamental catalyst like guidance, contracts, or financing.

    SEC EDGAR · Jun 9, 2026

  • The filing discloses a new unregistered equity/warrant issuance at a fixed purchase price, implying near-term dilution and financing overhang.

    SEC EDGAR 8-K · Jun 9, 2026

alphai scores every news story that mentions AWHL with an AI model for sentiment and relevance, and aggregates insider trades from Aspira Women's Health Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AWHL

Score
$AWHLMed

Aspira Women's Health Inc. (AWHL): Entry into a Material Definitive Agreement

Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 awhl-20260706xex10d1.htm EX-10.1 ​ SUBORDINATED BUSINESS LOAN AND SECURITY AGREEMENT ​ ​ THIS SUBORDINATED BUSINESS LOAN AND SECURITY AGREEMENT (as the same may be amended, restated, modified, or supplemented from time to time, this “ Agreement ”) dated as of July 01, 2

$AWHLMed

Aspira Women's Health Inc. (AWHL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Aspira Women's Health Inc._ June 17, 2026 Aspira Women's Health Inc. 0000926617 false 0000926617 2025-12-16 2025-12-16 ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC

$AWHLLow

Aspira Women's Health Inc. (AWHL): Submission of Matters to a Vote of Security Holders

Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Aspira Women's Health Inc._June 17, 2026 Aspira Women's Health Inc. 0000926617 false 0000926617 2026-01-30 2026-01-30 ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

Aspira Women's Health Inc. (AWHL): Entry into a Material Definitive Agreement

Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 awhl-20260529xex10d1.htm EX-10.1 ​ ​ ​ ​ ​ Exhibit 10.1 ​ SECURITIES PURCHASE AGREEMENT ​ This Securities Purchase Agreement (this “ Agreement ”) is dated as of June 5, 2026, between Aspira Women’s Health, Inc. , a Delaware corporation (the “ Company ”), and each purcha

Related tickers